metricas
covid
Buscar en
Revista de Senología y Patología Mamaria - Journal of Senology and Breast Disease
Toda la web
Inicio Revista de Senología y Patología Mamaria - Journal of Senology and Breast Dise... Primary breast fibromatosis in a male
Journal Information
Vol. 35. Issue 2.
Pages 140-141 (April - June 2022)
Share
Share
Download PDF
More article options
Visits
1013
Vol. 35. Issue 2.
Pages 140-141 (April - June 2022)
Images and videos
Full text access
Primary breast fibromatosis in a male
Fibromatosis mamaria en un hombre
Visits
1013
Fernando Hernanz
Corresponding author
cgdhff@humv.es

Corresponding author.
, Jaime Jimeno, Lucia Paz, Andrés Güezmes
Breast Unit, Hospital Universitario Marqués de Valdecilla, Santander, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

A 41-year-old man presented with a painless left breast lump. Mamography with a core needle biopsy (immunohistochemical study) and axillary echography ruled out carcinoma and enlarged lymph nodes; the histologic study suggested a breast fibromatosis. He was operated on and a tumorectomy was carried out.

Fig. 1 demonstrates a composition of images: radiological (mamography and mammary echography), surgical procedure (lumpectomy) and macroscopical aspect of surgical specimen. The definitive pathological diagnosis was breast fibromastosis.

Figure 1.

Radiological (mamography and mammary echography), surgical procedure (lumpectomy) and macroscopical aspect of surgical specimen.

(0.17MB).

Mammary fibromatosis is a bizarre clinical entity, rarely reported in men,1 but poses significant diagnostic and therapeutic challenges.2 It usually presents with a palpable, firm, and painless mass that is difficult to differentiate from breast carcinoma based solely on the imaging approach.2

The optimal management is unknown owing to its rarity, a wide local excision with negative margins is considered the treatment of choice. There is a significant risk of local recurrence, but no metastasis potential, therefore there should be a strict follow-up of patients for at least three years.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.

Informed consent was obtained from all individual participants included in the study.

Funding

None declared.

Conflict of interest

All authors declare that they have no conflict of interest.

References
[1]
M.R. Boland, T. Nugent, J. Nolan, J. O’Mahony, S. O’Keeffe, C.C. Gillham, et al.
Fibromatosis of the breast: a 10-year multi-institutional experience and review of the literatura.
Breast Cancer, 28 (2021), pp. 168-174
[2]
G.S. Schwarz, M. Drotman, R. Rosenblatt, L. Milner, J. Shamonki, M.P. Osborne.
Fibromatosis of the breast: case report and current concepts in the management of an uncommon lesion.
Copyright © 2021. SESPM
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos